Scpharmaceuticals Revenue vs. Shares Owned By Institutions
| SCPH Stock | USD 3.81 0.30 8.55% |
Total Revenue | First Reported 2015-12-31 | Previous Quarter 6.1 M | Current Value 6.1 M | Quarterly Volatility 1.7 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.58 | 0.65 |
|
|
For Scpharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Scpharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Scpharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Scpharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Scpharmaceuticals over time as well as its relative position and ranking within its peers.
Scpharmaceuticals |
Is Scpharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Scpharmaceuticals. If investors know Scpharmaceuticals will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Scpharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.48) | Revenue Per Share 0.454 | Quarterly Revenue Growth 1.958 | Return On Assets (0.36) | Return On Equity (1.15) |
The market value of Scpharmaceuticals is measured differently than its book value, which is the value of Scpharmaceuticals that is recorded on the company's balance sheet. Investors also form their own opinion of Scpharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Scpharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Scpharmaceuticals' market value can be influenced by many factors that don't directly affect Scpharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Scpharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Scpharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Scpharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Scpharmaceuticals Shares Owned By Institutions vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Scpharmaceuticals's current stock value. Our valuation model uses many indicators to compare Scpharmaceuticals value to that of its competitors to determine the firm's financial worth. Scpharmaceuticals is rated below average in revenue category among related companies. It is rated second in shares owned by institutions category among related companies . The ratio of Revenue to Shares Owned By Institutions for Scpharmaceuticals is about 179,730 . As of now, Scpharmaceuticals' Total Revenue is increasing as compared to previous years.Comparative valuation analysis is a catch-all model that can be used if you cannot value Scpharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Scpharmaceuticals' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Scpharmaceuticals' earnings, one of the primary drivers of an investment's value.Scpharmaceuticals Revenue vs. Competition
Scpharmaceuticals is rated below average in revenue category among related companies. Market size based on revenue of Health Care industry is at this time estimated at about 169.92 Million. Scpharmaceuticals holds roughly 13.59 Million in revenue claiming about 8% of equities under Health Care industry.
Scpharmaceuticals Shares Owned By Institutions vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Scpharmaceuticals |
| = | 13.59 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
Scpharmaceuticals |
| = | 75.63 % |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Scpharmaceuticals Shares Owned By Institutions Comparison
Scpharmaceuticals is currently under evaluation in shares owned by institutions category among related companies.
Scpharmaceuticals Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Scpharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Scpharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Scpharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Scpharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | (1,000.00) | (1,050) | |
| Operating Income | -55.4 M | -52.6 M | |
| Net Loss | -50.2 M | -47.7 M | |
| Income Before Tax | -54.8 M | -52.1 M | |
| Total Other Income Expense Net | 586 K | 615.3 K | |
| Net Loss | -33.2 M | -34.8 M | |
| Net Loss | -54.8 M | -52.1 M | |
| Income Tax Expense | 612.9 K | 582.3 K | |
| Net Interest Income | -3.2 M | -3.3 M | |
| Interest Income | 4.8 M | 5.1 M | |
| Non Operating Income Net Other | 3 M | 3.2 M | |
| Change To Netincome | 4.3 M | 3 M | |
| Net Loss | (1.42) | (1.49) | |
| Income Quality | 1.08 | 0.74 | |
| Net Income Per E B T | 1.17 | 1.16 |
Scpharmaceuticals Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Scpharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Scpharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Scpharmaceuticals' important profitability drivers and their relationship over time.
Use Scpharmaceuticals in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Scpharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scpharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Scpharmaceuticals Pair Trading
Scpharmaceuticals Pair Trading Analysis
The ability to find closely correlated positions to Scpharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Scpharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Scpharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Scpharmaceuticals to buy it.
The correlation of Scpharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Scpharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Scpharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Scpharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Scpharmaceuticals position
In addition to having Scpharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Munis Funds Thematic Idea Now
Munis Funds
Funds or Etfs that invest in fixed income securities issued by states, cities, and towns as well as other public entities. The Munis Funds theme has 48 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Munis Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map. For more detail on how to invest in Scpharmaceuticals Stock please use our How to Invest in Scpharmaceuticals guide.You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Scpharmaceuticals Stock analysis
When running Scpharmaceuticals' price analysis, check to measure Scpharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scpharmaceuticals is operating at the current time. Most of Scpharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Scpharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scpharmaceuticals' price. Additionally, you may evaluate how the addition of Scpharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |
To fully project Scpharmaceuticals' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Scpharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Scpharmaceuticals' income statement, its balance sheet, and the statement of cash flows.